CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- 4 Planned sale EVP and CMO sold 2,329 shares at $450.95 ($1,050,263)
- 4 Planned sale EVP and CMO sold 2,329 shares at $481.79 ($1,122,089)
- 4 Planned sale EVP, Chief Commercial Officer sold 2,633 shares at $498.42 ($1,312,340)
- 4 Planned sale EVP, Chief Commercial Officer sold 2,437 shares at $475.30 ($1,158,306)
- 4 Planned sale EVP and Chief Legal Officer sold 892 shares at $495.96 ($442,396)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale CEO & President sold 40,000 shares at an average $493.47 ($19,738,855)
- 4 Planned sale EVP and CMO sold 2,329 shares at $480.31 ($1,118,642)
- 4 Planned sale SVP & Chief Accounting Officer sold 357 shares at $483.36 ($172,560)
- 4 Shares withheld for taxes EVP, CO & FO gave up 1,744 shares (to pay taxes)
- 4 Planned sale EVP, Chief Reg. & Quality Off. sold 260 shares at $486.35 ($126,451)
- 4 Planned sale EVP Chief Patient & Ext Af Off sold 1,846 shares at $486.35 ($897,802)
- 4 Planned sale EVP, Chief Commercial Officer sold 4,910 shares at an average $487.65 ($2,394,365)
- 4 Shares withheld for taxes Executive Chairman gave up 3,547 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President gave up 4,981 shares (to pay taxes)
- 4 Planned sale EVP, Chief Scientific Officer sold 620 shares at $486.35 ($301,537)
- 4 Shares withheld for taxes EVP and CMO gave up 1,453 shares (to pay taxes)
- 4 Planned sale EVP and Chief Legal Officer sold 945 shares at $486.35 ($459,601)
- 4 Planned sale EVP, Chief Technical Ops. Off. sold 668 shares at $486.35 ($324,882)
- 4 Planned sale SVP & Chief Accounting Officer sold 223 shares at $486.35 ($108,456)
Page 3 of 129 · 2,566 filings